GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 16D5E3
Of the Field

DeviceTalks Boston 2026

D

eviceTalks Boston is the premier gathering for the MedTech industry on the East Coast, offering opportunities to engage with leading minds and pioneers in the medical device space. Attendees will dive into the latest innovations and build meaningful connections, with sessions covering robotics, product design, manufacturing innovations, and more. The event…

Visit the official site
18Voices
0Underwriters
0Exhibitors
11On the bill · sessions
17Companies · in total
§I

The Voices

Programmed at DeviceTalks, in alphabetical order.
Aaron Anderson
Sr. Manager, Healthcare & MedTech · NVIDIA
Aaron Burnett
CEO · Wheelhouse DMG
Amy Boelter
Head of Inclusive Research Operations · Abbott
Arianna Bresci
PhD, Postdoctoral Associate · MIT
Bindu Bandlamudi
Corporate Applications Engineer · Microchip Technology
Dan Buttermore
Vice President of Engineering · Vantedge Medical
Eric Benjamin
EVP & COO · Insulet
Gavin Braithwaite
CEO · Cambridge Polymer Group
Jeff Buterbaugh
Account Executive · Averna powered by Spherea
Kayleen M. Brown
Managing Editor · DeviceTalks
Lisa Anderson, PhD
President & Co-Founder · Paragonix Technologies, Inc.
Maria Berkman, MD
Partner · Vensana Capital
Mark Burchnall, PE
Engineering Director · PSN Labs
Nicole Black, PhD
Program Director · MedTech Innovator
Noland Arbaugh
The World's First Neuralink User · Neuralink
Rebecca Bader, PhD
Director of Regulatory Services · Cambridge Polymer Group
Soheil Ashkani, MD
Assistant Professor, Orthopaedic Surgery · Mass General Research Institute
Yossi Bar
CEO · LEM Surgical
§III

The Programme

Selected from 11 sessions on the bill.
  • 10:30 AM-11:20 AM

    Compact band-pass Raman spectroscopy for non-invasive continuous glucose monitoring

    Building on the first direct observation of glucose Raman signals from in-vivo skin, MIT researchers are advancing band-pass Raman spectroscopy as a path toward truly non-invasive,…

    Invent It
  • 10:30 AM-11:20 AM

    Expanding Access to Clinical Trials

    Nearly 40% of the U.S. population is ethnically and culturally diverse, yet African Americans and Hispanics account for only about 5% of clinical trial participants. This lack of r…

    Commercialize It
  • 10:30 AM-11:20 AM

    MedTech Innovator Pitch Session

    Listen to top graduates of the industry's Top startup accelerator!

    Invent It
  • 10:30 AM-11:20 AM

    More precise, predictable, and personalized surgery: How do we get there?

    With FDA approval in hand, Medtronic is moving forward with a commercialization strategy for its surgical robotic system, Hugo. Find out how the company intends to leverage its cur…

    Make It
  • 10:30 AM-11:20 AM

    The Future of Orthopedic Implants: What Changes First – Materials, Procedures, or Economics?

    This panel will examine the orthopedic implants market and how innovation is affecting the development of materials, surgical procedures, and overall economics of the industry. Wit…

    Make It
  • 11:30 AM-12:20 PM

    Greenberg Traurig: IP Strategy for Funding & Exits

    Intellectual Property (IP) is important for medical technology companies to attract funding and exits, whether M&A or IPO. Learn best practices and pitfalls to avoid in building st…

    Invent It
  • 11:30 AM-12:20 PM

    Infor: From Vision to Incision – AI’s Real-Time Role in the OR

    AI is no longer experimental in the OR—it’s delivering real clinical impact today. Join world‑renowned surgeons as they perform remote surgery while industry leaders from NVIDIA, M…

    Make It
  • 11:30 AM-12:20 PM

    Nissha Medical Technologies: Innovative Solutions to Enable Medical Device Technology and Cost Reduction

    Medical device OEMs continue to drive rapid innovation in the development of lifesaving and life enhancing technologies. To enable this progress, CDMOs must continually innovate, p…

    Make It
  • 8:45 AM-9:00 AM

    Opening Remarks

    Welcome to DeviceTalks Boston! Meet the editorial team and hear the highlights of the next two-days hitting the stage and show floor.

Intermission
Part the Second · For the Buyer

An audience of 17 companies, parsed from the program.

Seventeen companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
17Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

61% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite422%
  • Founder / Owner211%
  • VP-level16%
  • Director / Head of422%
  • Manager / Lead16%
  • Engineer · IC16%
  • Other roles528%

Of 18 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01Cambridge Polymer Group2V
  2. 02Abbott1V
  3. 03Averna powered by Spherea1V
  4. 04DeviceTalks1V
  5. 05Insulet1V
  6. 06LEM Surgical1V
  7. 07Mass General Research Institute1V
  8. 08MedTech Innovator1V
  9. 09Microchip Technology1V
  10. 10MIT1V
  11. 11Neuralink1V
  12. 12NVIDIA1V
  13. 13Paragonix Technologies, Inc.1V
  14. 14PSN Labs1V
04Fig. 04 — By Tier

Tiers were not disclosed for this convocation.